The vitamin D receptor (VDR) influences blood sugar regulation through several pathways: it modulates insulin secretion from pancreatic beta cells, affects insulin sensitivity in muscle and adipose tissue, and has anti-inflammatory effects. Common genetic variants in the VDR gene (e.g., FokI, BsmI, TaqI) have been associated with altered insulin resistance and type 2 diabetes risk in observational studies and meta-analyses. However, effect sizes are small, and findings are inconsistent across populations. Direct-to-consumer DNA tests often report these variants, but their predictive value for an individual's blood sugar is limited. The evidence is moderate: while there are plausible biological mechanisms and some replicated associations, no randomized controlled trial has proven that personalizing diet based on VDR genotype improves glycemic outcomes. Lifestyle factors (diet, exercise, vitamin D status) have a much larger impact. A practical takeaway: ensure adequate vitamin D levels, as deficiency clearly impairs glucose metabolism, regardless of VDR genotype.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-7aa6c224eda57ee66d2955b9